Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal MUSK Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This MUSK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 35-65 amino acids from the N-terminal region of human MUSK. |
STK11 Antibody (N-term I29) Rabbit Polyclonal Antibody (Pab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Chicken, Xenopus) |
| Conjugation | Unconjugated |
| Immunogen | This STK11 (LKB1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 14-44 amino acids from the N-terminal region of human STK11 (LKB1). |
Rabbit Polyclonal LRRK2 Antibody
| Applications | FC, ICC/IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Porcine, Primate, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to a C-terminal region, within residues 2507–2527 of the human LRRK2 protein, conjugated to KLH. [Swiss-Prot# Q5S007] |
Rabbit polyclonal DDR1 Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This DDR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 17-47 amino acids from the N-terminal region of human DDR1. |
Rabbit polyclonal AKT2 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 416-444 amino acids from the C-terminal region of human AKT2. |
Rabbit polyclonal ERBB2 Antibody(N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This ERBB2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-52 amino acids from the N-terminal region of human ERBB2. |
Rabbit polyclonal MAPK3 Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat, Monkey |
| Conjugation | Unconjugated |
| Immunogen | This MAPK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human MAPK3. |
Rabbit polyclonal MAPK1 Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Bovine, Xenopus) |
| Conjugation | Unconjugated |
| Immunogen | This MAPK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 154-183 amino acids from the Central region of human MAPK1. |
Rabbit polyclonal HCK Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Monkey) |
| Conjugation | Unconjugated |
| Immunogen | This HCK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 131-156 amino acids from the N-terminal region of human HCK. |
Goat Anti-CAMK2A Antibody
| Applications | FC, IF, PEP-ELISA, WB |
| Reactivities | Human, Mouse (Expected from sequence similarity: Rat, Dog) |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-PRTAQSEETRVWHR, from the internal region of the protein sequence according to NP_057065.2; NP_741960.1. |
Active filters
Reactivities
- Rat
Applications
- FC
Clonalities
- Polyclonal
Families
- Protein Kinase
Filter by
Category
Target Symbol
Antibody Hosts
Conjugates
Pathways
- ErbB signaling pathway (5)
- Pathways in cancer (5)
- Chemokine signaling pathway (4)
- Endometrial cancer (4)
- Fc gamma R-mediated phagocytosis (4)
- Focal adhesion (4)
- Glioma (4)
- Neurotrophin signaling pathway (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Prostate cancer (4)
- mTOR signaling pathway (4)
- Acute myeloid leukemia (3)
- Adherens junction (3)
- Axon guidance (3)
- B cell receptor signaling pathway (3)
- Bladder cancer (3)
- Chronic myeloid leukemia (3)
- Colorectal cancer (3)
- Fc epsilon RI signaling pathway (3)
- GnRH signaling pathway (3)
- Insulin signaling pathway (3)
- Long-term potentiation (3)
- MAPK signaling pathway (3)
- Melanogenesis (3)
- Melanoma (3)
- Oocyte meiosis (3)
- Progesterone-mediated oocyte maturation (3)
- Renal cell carcinoma (3)
- T cell receptor signaling pathway (3)
- Thyroid cancer (3)
- Toll-like receptor signaling pathway (3)
- VEGF signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Calcium signaling pathway (2)
- Dorso-ventral axis formation (2)
- Gap junction (2)
- Long-term depression (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Prion diseases (2)
- Regulation of actin cytoskeleton (2)
- TGF-beta signaling pathway (2)
- Type II diabetes mellitus (2)
- Vascular smooth muscle contraction (2)
- Apoptosis (1)
- Endocytosis (1)
- Jak-STAT signaling pathway (1)
- Olfactory transduction (1)
- Parkinson's disease (1)
- Small cell lung cancer (1)
- Tight junction (1)
- Wnt signaling pathway (1)